Low-Density Lipoprotein Cholesterol and the Risk of Rheumatoid Arthritis: A Prospective Study in a Chinese Cohort
Open Access
Abstract
Objective: This study aimed to investigate whether low-density lipoprotein cholesterol (LDL-C) concentration was associated with the risk of rheumatoid arthritis (RA) in Chinese adults. Methods: The study included the 97,411 participants in the Kailuan Study without RA, with complete baseline LDL-C data, and who did not use lipid-lowering medications at baseline or during follow-up. We used Cox proportional hazards modeling to calculate the hazard ratio (HR) and 95% confidence interval (95% CI) of RA according to baseline LDL-C tertiles, adjusting for age, sex, body mass index, HDL-C, triglycerides, diabetes, hypertension, alcohol consumption, and smoking. We also calculated the HR and 95% CI of RA using updated LDL-C measurements prior to the end of follow-up, adjusting for covariates. Results: We identified 97 incident RA cases between 2006 and 2018. After adjusting for potential confounders, updated LDL-C concentration—rather than baseline LDL-C—was inversely associated with RA risk. The adjusted HR of RA was 0.64 (95% CI: 0.38, 1.09; p-trend = 0.10) comparing the two extreme baseline LDL-C tertiles, and 0.38 (95% CI: 0.22, 0.64; p-trend < 0.01) comparing the two extreme tertiles of the updated LDL-C concentrations. Conclusions: In this prospective study, high LDL-C concentrations, when measured closest to RA diagnosis or the end of follow-up, were associated with a low risk of RA. These findings highlight the changes in LDL-C prior to RA diagnosis, and the importance of including lipid analyses into studies of the pathogenesis of RA.Keywords
Funding Information
- Pennsylvania State University (start-up grant)
This publication has 28 references indexed in Scilit:
- Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLENature Reviews Rheumatology, 2014
- Lipid and Lipoprotein Levels and Trend in Rheumatoid Arthritis Compared to the General PopulationArthritis Care & Research, 2013
- Changes in Lipoproteins Associated With Methotrexate Therapy or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis TrialArthritis & Rheumatism, 2013
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseAnnals of the Rheumatic Diseases, 2011
- Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic ReviewThe Journal of Rheumatology, 2010
- Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trialRheumatology, 2010
- Total cholesterol and LDL levels decrease before rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Patterns of cardiovascular risk in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort studyArthritis & Rheumatism, 2005